Metabolic Acidosis in Acute Intermittent Porphyria
Metabolic acidosis in acute intermittent porphyria is not a characteristic feature of the disease itself, and the provided evidence does not identify metabolic acidosis as a direct consequence of AIP pathophysiology.
Key Pathophysiological Features
The fundamental metabolic disturbances in AIP involve:
- Accumulation of neurotoxic porphyrin precursors (δ-aminolevulinic acid and porphobilinogen) due to ~50% deficiency of hydroxymethylbilane synthase (HMBS) 1
- Upregulation of hepatic ALAS1 (the rate-controlling enzyme), which drives overproduction of these toxic precursors 2, 3
Actual Metabolic Disturbances in AIP
The documented metabolic abnormalities during acute attacks include:
- Hyponatremia - frequently severe and resistant to correction 4, 5
- Hypokalemia - often resistant to replacement 4
- Alterations in carbohydrate, lipid, water, and electrolyte metabolism 2
- Impaired glucose metabolism with insulin resistance 3
None of the guideline or research evidence identifies metabolic acidosis as a typical manifestation of AIP 1.
Clinical Context
If metabolic acidosis occurs in a patient with AIP, consider:
- Alternative diagnoses or concurrent conditions causing the acidosis
- Complications from severe illness (e.g., lactic acidosis from seizures, sepsis, or organ dysfunction)
- Medication effects or other precipitating factors
The 2023 AGA guideline comprehensively reviews AIP pathophysiology and clinical manifestations without mentioning metabolic acidosis as a feature 1.
Important Caveat
The characteristic biochemical finding in AIP is elevated urinary porphobilinogen and δ-aminolevulinic acid (>5-fold elevation during attacks), not metabolic acidosis 6. The neurovisceral symptoms result from the neurotoxic effects of accumulated porphyrin precursors, not from acid-base disturbances.